Innovation Pharmaceuticals Inc (IPIX): But, K had spectacular results against K...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Re: P53dragon post# 27036

Sunday, 03/17/2013 1:43:31 PM

Sunday, March 17, 2013 1:43:31 PM

But, K had spectacular results against K562 Leukemia. For leukemia K seems type specific for sensitivity.

"It ain't what they call you, it's what
you answer to." --WC Fields

Keep Last Read

Replies (2) Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM

InvestorsHub NewsWire

FEATURED Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • Sep 10, 2024 11:00 AM

Only $200 per official company press release!